Article Versions Notes

Markoglou N, Simeakis G, Alevizaki M, Velonakis G, Chatzistamatiou T, Spyropoulou-Vlachou M, Stavropoulos-Giokas C, Stefanis L, Anagnostouli M. Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient’s COVID-19 Infection. Biomedicines. 2022; 10(11):2850. https://doi.org/10.3390/biomedicines10112850

Markoglou, Nikolaos, George Simeakis, Maria Alevizaki, Georgios Velonakis, Theofanis Chatzistamatiou, Maria Spyropoulou-Vlachou, Catherine Stavropoulos-Giokas, Leonidas Stefanis, and Maria Anagnostouli. 2022. "Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient’s COVID-19 Infection" Biomedicines 10, no. 11: 2850. https://doi.org/10.3390/biomedicines10112850

Markoglou, N., Simeakis, G., Alevizaki, M., Velonakis, G., Chatzistamatiou, T., Spyropoulou-Vlachou, M., Stavropoulos-Giokas, C., Stefanis, L., & Anagnostouli, M. (2022). Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient’s COVID-19 Infection. Biomedicines, 10(11), 2850. https://doi.org/10.3390/biomedicines10112850